✦ LIBER ✦

Differences in agonist/antagonist properties at human dopamine D2 receptors between aripiprazole, bifeprunox and SDZ 208-912

✍ Scribed by Yoshihiro Tadori; Hisashi Kitagawa; Robert A. Forbes; Robert D. McQuade; Arlene Stark; Tetsuro Kikuchi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Partial agonist properties of the antips

✍ Cristina Cosi; Elisabeth Carilla-Durand; Marie Bernadette Assié; Anne Marie Ormi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 473 KB

Aripiprazole and its human metabolite ar

✍ Martyn D. Wood; Claire Scott; Kirsten Clarke; Julie Westaway; Ceri H. Davies; Ch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 323 KB

Discriminative stimulus properties of S3

✍ Mark J. Millan; Loretta Iob; Jean-Louis Péglion; Anne Dekeyne 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 345 KB

P.3.d.001 In-vitro pharmacology of aripi

✍ Y. Tadori; A. Forbes; R. McQuade; T. Kikuchi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 96 KB